BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2249895)

  • 1. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
    Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
    Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of androgen receptor gene expression by steroids and retinoic acid in human breast-cancer cells.
    Hall RE; Tilley WD; McPhaul MJ; Sutherland RL
    Int J Cancer; 1992 Nov; 52(5):778-84. PubMed ID: 1428232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone receptors in breast cancer: more than estrogen receptors.
    Lamb CA; Vanzulli SI; Lanari C
    Medicina (B Aires); 2019; 79(Spec 6/1):540-545. PubMed ID: 31864223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and regulation of retinoic acid receptors in human breast cancer cells.
    Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
    Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and localization of steroid receptors in human nasal mucosa.
    Shirasaki H; Watanabe K; Kanaizumi E; Konno N; Sato J; Narita S; Himi T
    Acta Otolaryngol; 2004 Oct; 124(8):958-963. PubMed ID: 15536653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines.
    Lee CS; Hall RE; Alexander IE; Koga M; Shine J; Sutherland RL
    Growth Factors; 1990; 3(2):97-103. PubMed ID: 2206558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid receptors in rheumatoid arthritis.
    Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
    Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer.
    Ormandy CJ; Hall RE; Manning DL; Robertson JF; Blamey RW; Kelly PA; Nicholson RI; Sutherland RL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3692-9. PubMed ID: 9360527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense estrogen receptor RNA expression increases epidermal growth factor receptor gene expression in breast cancer cells.
    deFazio A; Chiew YE; McEvoy M; Watts CK; Sutherland RL
    Cell Growth Differ; 1997 Aug; 8(8):903-11. PubMed ID: 9269899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells.
    Berkenstam A; Glaumann H; Martin M; Gustafsson JA; Norstedt G
    Mol Endocrinol; 1989 Jan; 3(1):22-8. PubMed ID: 2915647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
    García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
    Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.
    Lau KM; Mok SC; Ho SM
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5722-7. PubMed ID: 10318951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.
    Classen S; Possinger K; Pelka-Fleischer R; Wilmanns W
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):315-9. PubMed ID: 8499339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.
    Konecny G; Pauletti G; Pegram M; Untch M; Dandekar S; Aguilar Z; Wilson C; Rong HM; Bauerfeind I; Felber M; Wang HJ; Beryt M; Seshadri R; Hepp H; Slamon DJ
    J Natl Cancer Inst; 2003 Jan; 95(2):142-53. PubMed ID: 12529347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
    Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
    Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro.
    Malewski T; Milewicz T; Krzysiek J; Gregoraszczuk EL; Augustowska K
    Cancer Invest; 2005; 23(3):222-8. PubMed ID: 15945508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic introduction of androgen receptor into estrogen-receptor-, progesterone-receptor-, and androgen-receptor-negative breast cancer cells renders them responsive to hormonal manipulation.
    Garreau JR; Muller P; Pommier R; Pommier S
    Am J Surg; 2006 May; 191(5):576-80. PubMed ID: 16647340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer.
    Sasaki M; Tanaka Y; Perinchery G; Dharia A; Kotcherguina I; Fujimoto Si; Dahiya R
    J Natl Cancer Inst; 2002 Mar; 94(5):384-90. PubMed ID: 11880477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.